1 I believe this is a well-conducted metaanalysis that compared the major cardiac events, target-lesion revascularisation, myocardial infarction and mortality rate in coronary arterial disease (CAD) patients with diabetes who were treated with sirolimus-eluting stents (SES) or bare-metal stent (BMS). However, there are some issues I would like to point out.
inspected visually to assess for publication bias in meta-analyses with at least 10 studies. Therefore, it was inappropriate.
Under the statistical analysis heading, the authors wrote 'Pooled ORs were obtained using the Mantel-Haenszel method in a fixed-effect model, and the DerSimonian-Laid method in a random-effects model'. However, it is not appropriate to use the Mantel-Haenszel method in a random-effects model to pool the data for all forest plots, regardless of heterogeneity.
It is very important in meta-analyses to evaluate methodological quality of included studies. However, the authors did not provide any methodological quality assessment or detailed scores for each trial in this article.
In conclusion, I agree with the results of this meta-analysis. SES are safer and more effective than BMS in CAD patients with diabetes, as far as major cardiac events are concerned. To reach a definitive conclusion, however, more high-quality studies with larger sample sizes are needed. 
